Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUSH-1: Dobutamine During Major Abdominal Surgery
NCT07000994Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dobutamine in myocardial depression (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Feasibility of dobutamine administration. Started Jun 2025; status: completed.
02
Drugs
dobutamine
03
Conditions
myocardial depression
Beyond the preview
Go deeper on NCT07000994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07000994.